Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Verrica Pharmaceuticals (VRCA) Operating Margin (2021 - 2025)

Historic Operating Margin for Verrica Pharmaceuticals (VRCA) over the last 5 years, with Q3 2025 value amounting to 11.34%.

  • Verrica Pharmaceuticals' Operating Margin rose 11738400.0% to 11.34% in Q3 2025 from the same period last year, while for Sep 2025 it was 53.21%, marking a year-over-year increase of 5547300.0%. This contributed to the annual value of 871.25% for FY2024, which is 4121000.0% up from last year.
  • As of Q3 2025, Verrica Pharmaceuticals' Operating Margin stood at 11.34%, which was up 11738400.0% from 11.89% recorded in Q2 2025.
  • In the past 5 years, Verrica Pharmaceuticals' Operating Margin ranged from a high of 17.41% in Q3 2022 and a low of 19159.46% during Q1 2023
  • Moreover, its 5-year median value for Operating Margin was 991.21% (2023), whereas its average is 3005.95%.
  • As far as peak fluctuations go, Verrica Pharmaceuticals' Operating Margin crashed by -174402000bps in 2023, and later skyrocketed by 186733400bps in 2024.
  • Over the past 5 years, Verrica Pharmaceuticals' Operating Margin (Quarter) stood at 0.5% in 2021, then crashed by -1826865bps to 9133.82% in 2022, then soared by 87bps to 1163.78% in 2023, then tumbled by -185bps to 3316.86% in 2024, then surged by 100bps to 11.34% in 2025.
  • Its Operating Margin stands at 11.34% for Q3 2025, versus 11.89% for Q2 2025 and 236.41% for Q1 2025.